MRI imaging technique offers insights into COVID-19 brain impact

Developed by a University of Waterloo engineer, the new imaging technique - correlated diffusion imaging (CDI) - was developed by systems design engineering professor Alexander Wong and recently used in a study by scientists at Baycrest’s Rotman Research Institute and Sunnybrook Hospital in Toronto.

“Some may think COVID-19 affects just the lungs,” Dr. Wong said in a statement. “What was found is that this new MRI technique that we created is very good at identifying changes to the brain due to COVID-19. COVID-19 changes the white matter in the brain.”

Wong, a Canada Research Chair in Artificial Intelligence and Medical Imaging, had previously developed CDI in a search for a better imaging measure for detecting cancer. CDI is a new form of MRI that can better highlight the differences in the way water molecules move in tissue by capturing and mixing MRI signals at different gradient pulse strengths and timings.

Researchers at Rotman thought Wong’s imaging discovery could be used to identify changes to the brain due to COVID-19, with subsequent tests proving the theory right. The CDI imaging of frontal-lobe white matter revealed a less restricted diffusion of water molecules in COVID-19 patients. It simultaneously showed a more restricted diffusion of water molecules in the cerebellum of patients with COVID-19.

MORE FROM MEDICAL & HEALTHCARE

Wong highlights that the two regions of the brain react differently to COVID-19 and points to two key findings from the research: first, the human cerebellum might be more vulnerable to COVID-19 infections; second, the study reinforces the idea that COVID-19 infections can lead to changes in the brain. 

According to the University of Waterloo, Rotman’s study is one of the few to have shown COVID-19’s effects on the brain, but it is the first to report diffusion abnormalities in the white matter of the cerebellum. Although the study was designed to show changes, rather than specific damage, to the brain from COVID-19, its final report does discuss potential sources of such changes and many link to disease and damage.

Wong suggests that future tests could focus on whether COVID-19 damages brain tissue, and additional studies could also determine if COVID-19 can change the brain’s grey matter. 

“Hopefully, this research can lead to better diagnoses and treatments for COVID-19 patients,” said Wong. “And that could just be the beginning for CDI as it might be used to understand degenerative processes in other diseases such as Alzheimer’s or to detect breast or prostate cancers.”

The study, Feasibility of diffusion-tensor and correlated diffusion imaging for studying white-matter microstructural abnormalities: Application in COVID-19, which involves Wong and his student Hayden Gunraj as co-authors, is published in Human Brain Mapping.